GEIST:UPC Searchengine

UPC_CFI_1/2023

Amgen, Inc. v. Sanofi-Aventis Deutschland GmbH

Date
2023-09-20
Division
Munich (DE) Central Division - Section
Type of action
Revocation Action
Language
EN

Metadata

Case IDUPC_CFI_1-2023-0c7d0a204eb3
Case number
Registry numberUPC_CFI_1/2023
Order referenceORD_550152/2023
Keywords
Headnotes

Documents and full text

Extractor: pypdf | Pages: 8

1 Central Division (Section Munich) UPC_CFI_1/2023 Order rejecting Rule 262.1(b) RoP request of the Court of First Instance of the Unified Patent Court delivered on 20/09/2023 HEADNOTES: Rule 262.1(b) RoP requires a concrete and verifiable, legitimate reason for making available written pleadings and evidence upon a request by a member of the public. The wish from a natural person to form an opinion on the validity of a patent out of a personal and a professional interest is not a legitimate reason as required by Rule 262.1(b) RoP. Keywords: Rule 262.1(b) RoP request (rejected). Legitimate reason for access (no). REFERENCE CODE ECLI: Not provided APPLICANT/S 1) … (Applicant) - … - … Represented by … … RESPONDENT/S 2 RELEVANT PROCEEDING PARTIES 1) Sanofi-Aventis Deutschland GmbH (Claimant)  ...